AbbVie (ABBV) looks to new drugs to boost sales following Humira competition - WSJ
Go back to AbbVie (ABBV) looks to new drugs to boost sales following Humira competition - WSJ| AbbVie (NYSE: ABBV) | Delayed: 234.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $234.89 | 52 Week High | $68.12 | |||
| Open | $234.89 | 52 Week Low | $50.71 | |||
| Day High | $234.89 | P/E | 50.95 | |||
| Day Low | $234.89 | EPS | $4.61 | |||
| Volume | 530 | |||||
